Clinical Trials Directory

Trials / Completed

CompletedNCT01283620

Atlantic Canada Modified Constraint Induced Movement Therapy Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Nova Scotia Health Authority · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effectiveness and feasibility of a modified constraint induced movement therapy (mCIMT) intervention on upper limb function in two groups of patients acutely post-stroke; 1) an experimental group that will participate in a 10 week mCIMT intervention designed to improve upper limb function, in addition to usual care, and 2) a control group that will participate in a program of usual care consisting of a rehabilitation intervention for the affected upper limb that is dose-matched to the experimental group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmodified constraint induced movement therapy (mCIMT)The intervention group will receive usual care plus mCIMT. mCIMT consists of two components delivered in parallel: three 30 min therapy sessions/week focusing on progressively more difficult tasks performed with the arm/hand, and five hours/weekday of restraint of the unaffected upper limb. Each 30 min therapy session consists of using the affected upper limb in practicing 4-5 functionally relevant tasks.
OTHERUsual and Customary CarePatients in this arm will receive usual care dose-matched to the experimental care group. Usual care will consist of occupational and physiotherapy intervention focused on affected upper limb range of motion (i.e., active range of motion incorporated into functional tasks such as reaching), strengthening (i.e., upper limb resisted exercise), manual dexterity exercises (i.e., grasp and release, stacking cones), and general aerobic conditioning (i.e., recumbent stepper, treadmill).

Timeline

Start date
2011-12-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2011-01-26
Last updated
2015-05-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01283620. Inclusion in this directory is not an endorsement.